Loading…
Patent Examination and Quality Improvement Act of 2022
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Patent Examination and Quality Improvement Act of 2022 This bill requires the Government Accountability Office to report to Congress on how to improve the patent examination process and the quality of issued patents. Within a year after the report is submitted to Congress, the U.S. Patent and Trademark Office must develop guidance for its patent examiners that take into consideration the report’s findings and recommendations.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2025 · first_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022, S.2140Patent Eligibility Restoration Act of 2023
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022, S.2140 Patent Eligibility Restoration Act of 2023
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2024 · third_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022, S.2140 Patent Eligibility Restoration Act of 2023
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2024 · second_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022, S.2140 Patent Eligibility Restoration Act of 2023
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2024 · first_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022, S.2140 Patent Eligibility Restoration Act of 2023
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2023 · fourth_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2023 · third_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2023 · second_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2023 · first_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, S.4704 Patent Examination and Quality Improvement Act of 2022
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S 2891 Restore the America Invents Act S. 2774 - Pride in Patent Ownership Act S. 4704 - Patent Examination and Quality Improvement Act of 2022 S. 4417 - Patent Trial and Appeal Board Reform Act of 2022 S. 4430 - Interagency Patent Coordination and Improvement Act of 2022 FTC related issues Issues related to the Patent Act Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill
Client expense: $2,140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues related to intellectual property legislation and regulation; S. 2891, Restoring the America Invents Act; S. 4704, Patent Examination and Quality Improvement Act of 2022; S. 2773, Unleashing American Innovators Act; S. 2774, Pride in Patent Ownership Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Intellectual property and patent issues; S. 2891, Restoring the America Invents Act; S. 4704, Patent Examination and Quality Improvement Act of 2022
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Patent Settlements. Patent Abuse. Skinny Labeling. Inter Partes Review. Impact of IPR decisions on 30-month stay. IPR Amendments. Enhancing Quality of Patents through the PTAB. S.2891: Restoring the America Invents Act. S.4417: Patent Trial and Appeal Board Reform Act of 2022. S.4430: Interagency Patent Coordination and Improvement Act of 2022. S.4704: Patent Examination and Quality Improvement Act of 2022. H.R.6381/S.3521: CREATE Act of 2022.
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
H.R. 1629: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 250: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act or 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matter relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4704: Patent Examination and Quality Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues
Client expense: $860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
H.R. 1629: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 250: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act of 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4704: Patent Examination and Quality Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues
Client expense: $6,610,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Patent Eligibility Restoration Act (S.4734) Restoring Americas Leadership in Innovation Act (H.R.5874) Unleashing American Innovators Act (S.2773/H.R.8697) Inventor Diversity for Economic Advancement Act (S.632/H.R.1723) Patent Examination and Quality Improvement Act (S.4704) Patent Trial and Appeal Board Reform Act (S.4417) Pride in Patent Ownership Act (S.2774)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Issues relating to legislation regarding patents; S. 2891, the Restoring the America Invents Act; S. 4417, Patent Trial and Appeal Board Reform Act of 2022; S. 2774, the Pride in Patent Ownership Act; S. 4704, the Patent Examination and Quality Improvement Act; S. 4734, the Patent Eligibility Restoration Act of 2022; H.R. 7900, S. 4543, the National Defense Authorization Act for Fiscal Year 2023.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S 2891 Restore the America Invents Act S. 2774 - Pride in Patent Ownership Act S. 4704 - Patent Examination and Quality Improvement Act of 2022 S. 4417 - Patent Trial and Appeal Board Reform Act of 2022 S. 4430 - Interagency Patent Coordination and Improvement Act of 2022 FTC related issues Issues related to the Patent Act Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill
Client expense: $2,140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, The Patent Trial and Appeal Board (PTAB) Reform Act of 2022 (draft), S.4704 Patent Examination and Quality Improvement Act of 2022.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
S. 4704, the Patent Examination and Quality Improvement Act of 2022 S. 4417, the PTAB Reform Act S. 4430, the Interagency Patent Coordination and Improvement Act of 2022. S. 3880, the SMART Copyright Act of 2022 S. 3772, the Defending American Courts Act H.R. 6769, the Pro Codes Act H.R. 6570, the REPAIR Act H.R. 5902, the CLEAR Patents Act of 2021 H.R. 5874, Restoring Americas Leadership in Innovation Act of 2021 S. 2774, Pride in Patent Ownership S. 2773, Unleashing American Innovators Act S. 2891, the Restoring the America Invents Act H.R. 5184, the Advancing Americas Interests Act H.R. 5374, the SHOP SAFE Act S, 3549, the Agricultural Right to Repair Act H.R. 4006 the Fair Repair Act H.R. 3978, To make it unlawful to send a demand letter in bad faith for a patent relating to COVID-19 related products H.R. 3429, the SHOP SAFE Act S. 1843, the SHOP SAFE Act S. 2067, the SECRETS Act S. 1924, the Protecting IP Act of 2021 S. 1294, the Protecting American Intellectual Property Act of 2021 S. 1245, CCP Trade Secrets Act S. 1159, To enhance the authority of U.S. Customs and Border Protection to share information S. 936, the INFORM Consumers Act H.R. 1367/S. 483, the Workforce Mobility Act of 2021 H.R. 1723/S. 632, IDEA Act H.R. 653, Research Advancing to Market Production for Innovators Act H.R. 192, Targeting Rogue and Opaque Letters Act H.R. 597, the Pandemic Treatment Access and Affordability Act of 2021 H.R. 153, Protecting Consumer Access to Generic Drugs Act of 2021 H.R. 704/S. 169, the ARTS Act H.R. 824, the Stop Chinas IP Theft Act S. 39, Protecting American Innovation and Development Act of 2021 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request H.R. 4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
2022 · fourth_quarter · Copyright/Patent/Trademark
S. 2891 -- Restoring the America Invents Act -- a bill to amend Title 35 USC to address matters related to the Patent Trial and Appeals Board -- overall S. 2774 -- Pride in Patent Ownership Act -- overall S. 2773 -- Unleashing American Innovation Act -- overall H.R. 5874 -- Restoring American Leadership in Innovaction Act -- overall S. 4417 -- Patent Trial and Appeals Board Reform Act -- overall S. 4543 -- National Defense Authorization Act -- regarding potential amendments related to patents S. 4734 -- Patent Eligibility Restoration Act -- overall S. 4430 -- Interagency Patent Coordination and Improvement Act -- overall S. 4704 -- Patent Examination and Quality Improvement Act -- overall Discussions on issue of march-in rights, PTAB reform overall, need for Section 101 reform
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · fourth_quarter · Copyright/Patent/Trademark
STRONGER Patents Act National Institute of Standards and Technology (NIST) proposed revisions to Rights to Inventions Made by Nonprofit Organizations and Small Business Firms under Government Grants, Contracts, and Cooperative Agreements and Licensing of Government-Owned Inventions (NIST Docket No. 201207-0327) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions H.R. 3035/S. 1683 (Preventing Foreign Attempts to Erode Healthcare Innovation Act) S. 1260 (Endless Frontier Act/United States Innovation and Competition Act) patent and intellectual property-related provisions and amendments H.R. 4521 (America COMPETES Act) H.R. 4792 (Countering Communist China Act) patent and intellectual property-related provisions H.R. 1934 (Promoting United States International Leadership in 5G Act) standards development for standards-essential patents and innovation Request for Information Regarding Patent Eligibility Jurisprudence Study (Docket No. PTO-P-2021-0032) Bayh-Dole Act march-in misuse demands, including opposition to KEI petition to Health & Human Services to march in on Astellas patents on Xtandi Bayh-Dole Act exceptions to statutory licensing provisions, unilaterally imposed by Energy Dept. requiring DOE review of all licensing agreements grantees negotiate in technology transfers Patent & Trademark Office/PTAB discretion to institute or to deny trials before the Patent Trial and Appeal Board, pursuant to America Invents Act discretion; PTAB designation of precedential opinions, including the Fintiv doctrine to avoid duplicative litigation on the same patent claims in multiple forums S. 2891 (Restoring the America Invents Act) S. 2774 (Pride in Patent Ownership Act) H.R. 5874 (Restoring Americas Leadership in Innovation Act) Patent Trial and Appeal Board amicus re OpenSky Industries LLC v. VLSI Technology LLC (Case No. IPR2021-01064) Draft Policy Statement on Licensing Negotiations and Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments (Docket No. ATR-2021-0001) Patent eligibility/Section 101 Access to injunctive relief against patent infringers Patent Trial and Appeal Board amicus re Palo Alto Networks Inc. v. Centripetal Networks Inc. (Case No. IPR2022-00182) Patent Trial and Appeal Board amicus re OpenSky Industries LLC and Intel Corp.v. VLSI Technology LLC (Case No. IPR2021-01064) and Patent Quality Assurance LLC and Intel Corp. v. VLSI Technology LLC (Case No. IPR2021-01229) S. 3772 (Defending American Courts Act) S. 4417 (PTAB Reform Act) S. 4430 (Interagency Patent Coordination and Improvement Act) S. 4704 (Patent Examination and Quality Improvement Act) S. 4734 (Patent Eligibility Restoration Act) Request for Comments Regarding the Patent Subject Matter Eligibility Guidance (Docket No. PTO-P-2022-0026) Patent Trial and Appeal Board amicus re Samsung Electronics Co. v. Netlist, Inc. (Case No. IPR2022-00615) H.R. 2617 (legislative vehicle for the Consolidated Appropriations Act FY 2023 with Senate amendment #6552) potential patent-related policy riders
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE
2022 · third_quarter · Copyright/Patent/Trademark
H.R. 5874 - Restoring Americas Leadership in Innovation Act (RALIA) H.R. 8697 - Unleashing American Innovators Act H.R. 1723 - Inventor Diversity for Economic Advancement (IDEA) Act S. 2774 - Pride in Patent Ownership Act S.4734 - Patent Eligibility Restoration Act of 2022 S.2773 - Unleashing American Innovators Act S.632 - Inventor Diversity for Economic Advancement (IDEA) Act S.4704 - Patent Examination and Quality Improvement Act S.4417 - Patent Trial and Appeal Board (PTAB) Reform Act -- regarding policy issues affecting higher education institutions and their faculty and students
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Copyright/Patent/Trademark
Issues relating to legislation regarding patents; S. 2891, the Restoring the America Invents Act; S. 4417, Patent Trial and Appeal Board Reform Act of 2022; S. 2774, the Pride in Patent Ownership Act; S. 4704, the Patent Examination and Quality Improvement Act; S. 4734, the Patent Eligibility Restoration Act of 2022; H.R. 7900, S. 4543, the National Defense Authorization Act for Fiscal Year 2023.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Copyright/Patent/Trademark
H.R. 1629: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 250: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act of 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4704: Patent Examination and Quality Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues
Client expense: $7,270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · third_quarter · Copyright/Patent/Trademark
Patent Eligibility Restoration Act (S.4734) Restoring Americas Leadership in Innovation Act (H.R.5874) Unleashing American Innovators Act (S.2773/H.R.8697) Inventor Diversity for Economic Advancement Act (S.632/H.R.1723) Patent Examination and Quality Improvement Act (S.4704) Patent Trial and Appeal Board Reform Act (S.4417) Pride in Patent Ownership Act (S.2774)
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Copyright/Patent/Trademark
Patent Settlements. Patent Abuse. Skinny Labeling. REMEDY Act. Patent Listings in Orange Book. Inter Partes Review. Impact of IPR decisions on 30-month stay. IPR Amendments. S.4734: Patent Eligibility Restoration Act of 2022. Section 101 of the Patent Act. Product Hopping. TAB Appointments Clause (Arthrex Case). Enhancing Quality of Patents through the PTAB. S.2891: Restoring the America Invents Act. S.4417: Patent Trial and Appeal Board Reform Act of 2022. S.4430: Interagency Patent Coordination and Improvement Act of 2022. S.4704: Patent Examination and Quality Improvement Act of 2022. H.R.6381/S.3521: CREATE Act of 2022.
Client expense: $720,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · third_quarter · Copyright/Patent/Trademark
Issues related to intellectual property legislation and regulation; S. 2891, Restoring the America Invents Act; S. 4704, Patent Examination and Quality Improvement Act of 2022
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · third_quarter · Copyright/Patent/Trademark
Intellectual property and patent issues; S. 2891, Restoring the America Invents Act; S. 4704, Patent Examination and Quality Improvement Act of 2022
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Copyright/Patent/Trademark
Biopharmaceutical innovation and intellectual property policy issues; Interagency Patent Coordination and Improvement Act of 2022 (S. 4430); Patent Eligibility Restoration Act of 2022 (S. 4734); Patent Examination and Quality Improvement Act of 2022 (S. 4704).
Client expense: Not reported · Firm income: $360,000
2022 · third_quarter · Copyright/Patent/Trademark
Ensuring a level playing field for open-source software and services in government policy; Promoting open-source innovation; Issues related to patent law, issues related to patent quality; Implementation of Leahy-Smith America Invents Act of 2011 (H.R. 1249-112th); issues related to Trademark law; issues related to Copyright law; S.2774 - Pride in Patent Ownership, The Patent Trial and Appeal Board (PTAB) Reform Act of 2022 (draft), S.4704 Patent Examination and Quality Improvement Act of 2022.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2022 · third_quarter · Copyright/Patent/Trademark
S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S 2891 Restore the America Invents Act S. 2774- Pride in Patent Ownership Act S. 4704- Patent Examination and Quality Improvement Act of 2022 S. 4417- Patent Trial and Appeal Board Reform Act of 2022 S. 4430- Interagency Patent Coordination and Improvement Act of 2022 FTC related issues, no specific bill Issues related to the Patent Act Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill Mergers and acquisitions, no specific bill
Client expense: $3,150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Copyright/Patent/Trademark
S. 2891 -- Restoring the America Invents Act -- a bill to amend Title 35 USC to address matters related to the Patent Trial and Appeals Board -- overall S. 2774 -- Pride in Patent Ownership Act -- overall S. 2773 -- Unleashing American Innovation Act -- overall H.R. 5874 -- Restoring American Leadership in Innovaction Act -- overall S. 4417 -- Patent Trial and Appeals Board Reform Act -- overall S. 4543 -- National Defense Authorization Act -- regarding potential amendments related to patents S. 4734 -- Patent Eligibility Restoration Act -- overall S. 4430 -- Interagency Patent Coordination and Improvement Act -- overall S. 4704 -- Patent Examination and Quality Improvement Act -- overall Discussions on issue of march-in rights, PTAB reform overall, need for Section 101 reform
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Copyright/Patent/Trademark
STRONGER Patents Act National Institute of Standards and Technology (NIST) proposed revisions to Rights to Inventions Made by Nonprofit Organizations and Small Business Firms under Government Grants, Contracts, and Cooperative Agreements and Licensing of Government-Owned Inventions (NIST Docket No. 201207-0327) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions H.R. 3035/S. 1683 (Preventing Foreign Attempts to Erode Healthcare Innovation Act) S. 1260 (Endless Frontier Act/United States Innovation and Competition Act) patent and intellectual property-related provisions and amendments H.R. 4521 (America COMPETES Act) H.R. 4792 (Countering Communist China Act) patent and intellectual property-related provisions H.R. 1934 (Promoting United States International Leadership in 5G Act) standards development for standards-essential patents and innovation Request for Information Regarding Patent Eligibility Jurisprudence Study (Docket No. PTO-P-2021-0032) Bayh-Dole Act march-in misuse demands, including opposition to KEI petition to Health & Human Services to march in on Astellas patents on Xtandi Bayh-Dole Act exceptions to statutory licensing provisions, unilaterally imposed by Energy Dept. requiring DOE review of all licensing agreements grantees negotiate in technology transfers Patent & Trademark Office/PTAB discretion to institute or to deny trials before the Patent Trial and Appeal Board, pursuant to America Invents Act discretion; PTAB designation of precedential opinions, including the Fintiv doctrine to avoid duplicative litigation on the same patent claims in multiple forums S. 2891 (Restoring the America Invents Act) S. 2774 (Pride in Patent Ownership Act) H.R. 5874 (Restoring Americas Leadership in Innovation Act) Patent Trial and Appeal Board amicus re OpenSky Industries LLC v. VLSI Technology LLC (Case No. IPR2021-01064) Draft Policy Statement on Licensing Negotiations and Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments (Docket No. ATR-2021-0001) Patent eligibility/Section 101 Access to injunctive relief against patent infringers Patent Trial and Appeal Board amicus re Palo Alto Networks Inc. v. Centripetal Networks Inc. (Case No. IPR2022-00182) Patent Trial and Appeal Board amicus re OpenSky Industries LLC and Intel Corp.v. VLSI Technology LLC (Case No. IPR2021-01064) and Patent Quality Assurance LLC and Intel Corp. v. VLSI Technology LLC (Case No. IPR2021-01229) S. 3772 (Defending American Courts Act) S. 4417 (PTAB Reform Act) S. 4430 (Interagency Patent Coordination and Improvement Act) S. 4704 (Patent Examination and Quality Improvement Act) S. 4734 (Patent Eligibility Restoration Act) Request for Comments Regarding the Patent Subject Matter Eligibility Guidance (Docket No. PTO-P-2022-0026)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE